IGC Receives Another Patent for a Cannabinoid-Based Cream for Treating Pain
India Globalization Capital, Inc. (the “Company”) (NYSE
American: IGC) announced today that on March 2, 2021, the Company
received one more patent (patent#10,933,082) from the United States
Patent and Trademark Office (“USPTO”) for the Company’s cannabinoid
composition and method for treating pain in patients with Psoriatic
Arthritis, Fibromyalgia, Scleroderma and other conditions. The
patent application was filed on October 1, 2018. The latest patent
approval adds to the Company’s existing patent portfolio, which
includes patent issuances by the USPTO for seizure disorders and
IGC operates two lines of business: (i) infrastructure and (ii)
life sciences. The Company is based in Potomac, Maryland, U.S.A.
social media: www.igcinc.us, www.igcpharma.com, Twitter @IGCIR.
version on businesswire.com: https://www.businesswire.com/news/home/20210308005927/en/
Claudia Grimaldi email@example.com Phone: 301-983-0998